A detailed history of Black Rock Inc. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,546,069 shares of FHTX stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,546,069
Previous 1,315,371 17.54%
Holding current value
$12.5 Million
Previous $8.83 Million 0.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.05 - $8.0 $1.17 Million - $1.85 Million
230,698 Added 17.54%
1,546,069 $8.89 Million
Q1 2024

May 10, 2024

BUY
$2.82 - $7.94 $26,798 - $75,453
9,503 Added 0.73%
1,315,371 $8.83 Million
Q4 2023

Feb 13, 2024

SELL
$2.94 - $6.76 $252,516 - $580,616
-85,890 Reduced 6.17%
1,305,868 $8.42 Million
Q3 2023

Nov 13, 2023

SELL
$5.0 - $9.87 $318,405 - $628,531
-63,681 Reduced 4.38%
1,391,758 $6.96 Million
Q2 2023

Aug 11, 2023

BUY
$5.37 - $8.84 $1.14 Million - $1.88 Million
212,919 Added 17.14%
1,455,439 $10.2 Million
Q1 2023

May 12, 2023

SELL
$4.66 - $8.99 $34,987 - $67,496
-7,508 Reduced 0.6%
1,242,520 $7.7 Million
Q4 2022

Feb 13, 2023

BUY
$5.44 - $9.46 $1.05 Million - $1.82 Million
192,850 Added 18.24%
1,250,028 $7.98 Million
Q3 2022

Nov 14, 2022

SELL
$7.52 - $18.01 $199,249 - $477,192
-26,496 Reduced 2.45%
1,057,178 $9.07 Million
Q2 2022

Aug 12, 2022

SELL
$8.48 - $16.84 $279,500 - $555,046
-32,960 Reduced 2.95%
1,083,674 $14.7 Million
Q1 2022

May 12, 2022

SELL
$8.87 - $22.1 $277,976 - $692,591
-31,339 Reduced 2.73%
1,116,634 $17 Million
Q4 2021

Feb 10, 2022

BUY
$10.79 - $22.87 $305,227 - $646,946
28,288 Added 2.53%
1,147,973 $26.3 Million
Q3 2021

Nov 09, 2021

BUY
$8.33 - $15.02 $215,122 - $387,891
25,825 Added 2.36%
1,119,685 $15.6 Million
Q2 2021

Aug 11, 2021

BUY
$9.32 - $13.26 $10.2 Million - $14.5 Million
1,093,860 New
1,093,860 $11.7 Million

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.